InfuSystem Holdings (INFU) Change in Receivables (2010 - 2026)
InfuSystem Holdings (INFU) posted Change in Receivables of $2.2 million for Q1 2026, up 192.59% on a QoQ basis from -$2.4 million in Q4 2025, and up 7.4% year-over-year from $2.1 million in Q1 2025.
InfuSystem Holdings (INFU) Change in Receivables (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Change in Receivables history runs 11 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- Quarterly Change in Receivables rose 7.4% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$108000.0 (down 104.22% YoY) and the FY2025 annual result came in at -$263000.0, down 137.52% from the prior year.
- Change in Receivables was $2.2 million for Q1 2026 at InfuSystem Holdings, up from -$2.4 million in the prior quarter.
- Across five years, Change in Receivables topped out at $2.2 million in Q1 2026 and bottomed at -$2.4 million in Q4 2025.
- A 5-year average of $364941.2 and a median of $237000.0 in 2024 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2022 — Change in Receivables tumbled 289.01% — and 2025, when it soared 783.97%.
- InfuSystem Holdings' Change in Receivables stood at $546000.0 in 2022, then soared by 143.22% to $1.3 million in 2023, then plunged by 148.72% to -$647000.0 in 2024, then tumbled by 275.58% to -$2.4 million in 2025, then soared by 192.59% to $2.2 million in 2026.
- Business Quant data shows INFU's Change in Receivables at $2.2 million in Q1 2026, -$2.4 million in Q4 2025, and $78000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 2.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.25 Mn |
| Mar 31, 2026 | 2.25 Mn |
| Dec 31, 2025 | -2.43 Mn |
| Dec 31, 2025 | -2.43 Mn |
| Sep 30, 2025 | 78,000.00 |
| Sep 30, 2025 | 78,000.00 |
| Jun 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -6,000.00 |
| Mar 31, 2025 | 2.10 Mn |
| Mar 31, 2025 | 2.10 Mn |
| Dec 31, 2024 | -647,000.00 |
| Dec 31, 2024 | -647,000.00 |
| Sep 30, 2024 | 145,000.00 |
| Sep 30, 2024 | 145,000.00 |
| Jun 30, 2024 | 966,000.00 |
| Jun 30, 2024 | 966,000.00 |
| Mar 31, 2024 | 237,000.00 |
| Mar 31, 2024 | 237,000.00 |
| Dec 31, 2023 | 1.33 Mn |
| Dec 31, 2023 | 1.33 Mn |